Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract

被引:118
作者
Nanda, A
O'Connor, M
Anand, M
Dreskin, SC
Zhang, LE
Hines, B
Lane, D
Wheat, W
Routes, JM
Sawyer, R
Rosenwasser, LJ
Nelson, HS
机构
[1] Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Div Clin Immunol & Allergy,Dept Med, Denver, CO 80206 USA
[2] Natl Jewish Med & Res Ctr, Div Biostat, Gen Clin Res Ctr, Denver, CO USA
[3] Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Denver, CO USA
关键词
immunotherapy; cat immunotherapy; cluster; dose response; cat extract; immunologic response;
D O I
10.1016/j.jaci.2004.08.049
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The immunologic response to allergen immunotherapy with 3 serial 5-fold doses of cat extract has been studied after approximately 5 weeks of immunotherapy. The highest dose containing 15 mug of Fel d 1 produced the most consistent and favorable response. It is unknown whether the comparative response on reaching a maintenance dose is maintained with long-term maintenance therapy. Objective: The purpose of this investigation was to evaluate the immunologic responses with these 3 serial doses of cat hair and dander extract at baseline, after reaching the maintenance dose (approximately 5 weeks), and after 1 year of maintenance immunotherapy. Methods: Twenty-eight patients with cat allergy randomized in a double-blind study were assigned to one of 4 treatment groups: placebo or cat hair and dander extract containing 0.6 mug of Fel d 1, 3 mug of Fel d 1, and 15 mug of Fel d 1 at maintenance. Studies included skin prick tests and late cutaneous reactions with cat hair and dander extract, titrated nasal challenges with the extract, serum cat allergen-specific IgG4 and IgE measurement, and flow cytometric and ELISA analysis of whole blood and intranasal cytokines (TGF-beta, IL-10, IFN-gamma, IL-4, and IL-5). Results: Twenty-six subjects completed the study. After both 5 weeks and I year, significant and dose-dependent differences were seen with total symptom scores on nasal challenge (P <.0001), with titrated skin prick testing with cat dander extract at 5 weeks (P =.014) and 1 year (P <.0001), and with cat-specific IgG4 measurement at 5 weeks (P =.004) and I year (P =.003). At 1 year, neither flow cytometry of whole blood nor ELISA evaluation of nasal cytokines demonstrated any significant differences among the treatment groups. Conclusion: The response to titrated nasal allergen challenge, titrated skin prick testing, and allergen-specific IgG4 measurement to cat immunotherapy at 5 weeks is predictive of the response at 1 year.
引用
收藏
页码:1339 / 1344
页数:6
相关论文
共 29 条
[1]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[2]   MONOCLONAL ANTIBODY-STANDARDIZED CAT EXTRACT IMMUNOTHERAPY - RISK-BENEFIT EFFECTS FROM A DOUBLE-BLIND PLACEBO STUDY [J].
ALVAREZCUESTA, E ;
CUESTAHERRANZ, J ;
PUYANARUIZ, J ;
CUESTAHERRANZ, C ;
BLANCOQUIROS, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (03) :556-566
[3]   Do CD4+CD25+ immunoregulatory T cells hinder tumor immunotherapy? [J].
Antony, PA ;
Restifo, NP .
JOURNAL OF IMMUNOTHERAPY, 2002, 25 (03) :202-206
[4]   Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects [J].
Bellinghausen, I ;
Metz, G ;
Enk, AH ;
Christmann, S ;
Knop, J ;
Saloga, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) :1131-1139
[5]   NASAL CHALLENGE WITH POLLEN GRAINS, SKIN-PRICK TESTS AND SPECIFIC IGE IN PATIENTS WITH GRASS-POLLEN ALLERGY [J].
BOUSQUET, J ;
LEBEL, B ;
DHIVERT, H ;
BATAILLE, Y ;
MARTINOT, B ;
MICHEL, FB .
CLINICAL ALLERGY, 1987, 17 (06) :529-536
[6]  
Coligan JE, 2004, CURRENT PROTOCOLS IM
[7]   DOSE-RESPONSE OF IGE AND IGG ANTIBODIES DURING RAGWEED IMMUNOTHERAPY [J].
CRETICOS, PS ;
VANMETRE, TE ;
MARDINEY, MR ;
ROSENBERG, GL ;
NORMAN, PS ;
ADKINSON, NF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (01) :94-104
[8]   RESPONSES TO RAGWEED-POLLEN NASAL CHALLENGE BEFORE AND AFTER IMMUNOTHERAPY [J].
CRETICOS, PS ;
MARSH, DG ;
PROUD, D ;
KAGEYSOBOTKA, A ;
ADKINSON, NF ;
FRIEDHOFF, L ;
NACLERIO, RM ;
LICHTENSTEIN, LM ;
NORMAN, PS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (02) :197-205
[9]   Measurement of changes in mRNA for IL-5 in noninvasive scrapings of nasal epithelium taken from patients undergoing nasal allergen challenge [J].
Dreskin, SC ;
Dale, SN ;
Foster, SM ;
Martin, D ;
Buchmeier, A ;
Nelson, HS .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 268 (02) :189-195
[10]   A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract [J].
Ewbank, PA ;
Murray, J ;
Sanders, K ;
Curran-Everett, D ;
Dreskin, S ;
Nelson, HS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) :155-161